Original article

Blood Transfusion - 1 2022 (January-February)

Molecular characterization of rare D--/D-- variants in individuals of Indian origin

Authors

Key words: rare blood group, RHD variants, rearrangement, RHD-RHCE hybrid, D--
Publication Date: 2020-11-27

Abstract

Background - Rh antigens are critical in haemolytic disease of the foetus and newborn (HDFN). The D-- phenotype is a rare blood group characterised by the lack of expression of C, c, E and e antigens at the surface of red blood cells because of mutations in both RHCE alleles inactivating the expression of a "normal" protein. The aim of the study was to determine the molecular basis of D-- individuals of Indian origin.
Materials and methods - Ten Rh D-positive postnatal women who had produced antibodies against all Rh antigens, except D, leading to HDFN and foetal loss, were investigated. Extensive serological and molecular (polymerase chain reaction [PCR] using sequence-specific primers), quantitative multiplex PCR of short fluorescent fragments (QMPSF), and Sanger sequencing analyses were carried out.
Results - Serological testing with anti-C, anti-c, anti-E, and anti-e reagents showed absence of the four antigens in all ten index cases, as well as in three siblings. Flow cytometry indicated absence of these antigens with a typical exalted expression of the D antigen, thus confirming the rare D-- phenotype. Molecular analysis by QMPSF suggested homozygous CE-D hybrid alleles causing the D-- phenotype: RHCE-D(3-9)-CE (n = 11), RHCE-D(3-8)-CE (n=1), and RHCE-D(2-6)-CE (n=1).
Discussion - For the first time, we report the molecular basis of the D-- phenotype in the Indian population. Identification and characterisation of RHCE-null variants by molecular methods can help resolve transfusion-related problems in these individuals. Family studies of index cases helped to identify rare blood donors and offer counselling to females of child-bearing age on the complications involved in such pregnancies.

References

Downloads

Authors

Swati Kulkarni 1Department of Transfusion Medicine, ICMR-National Institute of Immunohaematology, Mumbai, India

Garima Mishra 1Department of Transfusion Medicine, ICMR-National Institute of Immunohaematology, Mumbai, India

Harita Maru Department of Transfusion Medicine, ICMR-National Institute of Immunohaematology, Mumbai, India

Disha Parchure Department of Transfusion Medicine, ICMR-National Institute of Immunohaematology, Mumbai, India

Debasish Gupta Department of Transfusion Medicine, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, India

Anantpreet Kaur Bajaj Department of Immunhaematology and Blood Transfusion, Armed Forces Medical College, Pune, India

Sangeeta Pahuja Sindhwani Department of Immunhaematology and Blood Transfusion, Lady Hardinge Medical College, New Delhi, India

Anand Chaphekar KEM Hospital Blood Bank, Pune, India

Ripal Shah Prathama Blood Centre, Ahmedabad, India

Claude Férec Génétique, Génomique Fonctionnelle et Biotechnologies", INSERM, EFS, Université de Brest, UMR1078, IBSAM, Brest, France; Service de Génétique Médicale, Centre Hospitalier Régional et Universitaire (CHRU) de Brest, Hôpital Morvan, Brest, France

Manisha Madkaikar Department of Transfusion Medicine, ICMR-National Institute of Immunohaematology, Mumbai, India

Yann Fichou Génétique, Génomique Fonctionnelle et Biotechnologies", INSERM, EFS, Université de Brest, UMR1078, IBSAM, Brest, France; Laboratory of Excellence (LabEx) GR-Ex, Paris, France

  • Abstract viewed - 706 times
  • PDF downloaded - 289 times